Myocardial Infarction Treatment Market is expected to grow at a significant rate during the forecast period 2018-2023. The myocardial infarction or heart attack is a life-threatening condition that occurs due to the blockage of one or more coronary arteries and the blockage in the blood flow to the heart muscle. There are various death cases recorded due to severe heart stroke or heart attacks. The myocardial infarction is of three type which are STEMI heart attacks, NSTEMI heart attacks, and silent heart attacks. Such diseases can be diagnosed by electrocardiography, chest x-ray, CT scan, echocardiography, blood test, and another diagnostic test. Moreover, the heart attack can be treated by several medications such as aspirin thrombolytic, antiplatelet agents, and others medicines and some surgical procedures such as angioplasty bypass surgery, heart transplant, and so on. Some of the devices used for the treatment of myocardial infarction includes left ventricular assist devices, pacemaker, and implantable cardioverter defibrillator.
Get Free Sample Copy @ https://www.omrglobal.com/request-sample/myocardial-infarction-treatment-market
Factors contributing to the growth of the myocardial infarction market includes rising incidence rate of CVDs (cardiovascular diseases) and intake of high-level sugary food, which significantly boost the prevalence of CADs (coronary artery diseases). Moreover, the shift towards sedentary lifestyle and faulty dietary habits coupled with lack of physical activities are some other factors that fuel the growth of the market. The high cost of myocardial infarction treatment and delay in certification for heart treatment are some factors restraining the growth of the market. However, the supportive laws and schemes for the reduction and prevention of heart diseases and the rising adoption of minimally invasive treatment are anticipated to create the future opportunity for the growth of the myocardial infarction market.
Browse for Full Report [email protected]
Global Myocardial Infarction Treatment Market by Type
• ST segment elevation myocardial infarction (STEMI) Heart Attacks
• Non-ST segment elevation myocardial infarction (NSTEMI) Heart Attacks
• Silent Heart Attacks
Global Myocardial Infarction Treatment Market by Device
• Left Ventricular Assist Device
• Implantable Cardioverter Defibrillator
• Others (Aspiration-Based Catheters)
Global Myocardial Infarction Treatment Market by Diagnosis
• Chest X-Ray
• Computed Tomography (CT Scan)
• Others (Blood Test)
Global Myocardial Infarction Treatment Market by Treatment
• Antiplatelet Agents
• Glycoprotein IIb/IIIa Inhibitors
• Others (Adrenergic Blockers)
• Bypass Surgery
• Heart Transplant
Global Myocardial Infarction Treatment Market by End-Users
• Hospital & Clinics
• Ambulatory Surgical Centers
• Research Institutes
• Key Strategy Analysis
• Key Company Analysis
• United States
• Rest of Asia-Pacific
Rest of the World (RoW)
• advanceCOR GmbH
• Anthera Pharmaceuticals, Inc.
• AstraZeneca PLC
• Athersys, Inc.
• Bayer AG
• BioVascular, Inc.
• Boehringer Ingelheim International GmbH
• BRISTOL-MYERS SQUIBB CO.
• Caladrius Biosciences, Inc.
• 7.10. Capricor Therapeutics, Inc.
• CSL Behring
• GlaxoSmithKline PLC
• GNT Pharma Co., Ltd
• Johnson & Johnson Services, Inc.
• Merck KGaA
• Mesoblast Ltd
• Mylan N.V.
• NeuroVive Pharmaceutical AB
• Novartis AG
• Osiris Therapeutics, Inc.
• Pfizer Inc.
• PledPharma AB
• Portola Pharmaceuticals, Inc.
• Sandoz International GmbH
• Sanofi SA
• Teva Pharmaceutical Industries Ltd.
• Ventrix, Inc.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/myocardial-infarction-treatment-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404